- £239.84m
- £322.31m
- £359.40m
- 56
- 89
- 27
- 60
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 380 | 222 | 231 | 341 | 359 |
Cost of Revenue | |||||
Gross Profit | 81 | 40.5 | 55.5 | 81.6 | 76.8 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 331 | 214 | 195 | 295 | 319 |
Operating Profit | 48.9 | 8.29 | 35.6 | 46.5 | 40.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 49.1 | 17.1 | 35.1 | 45.6 | 37.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 39.5 | 13.7 | 30.7 | 37.9 | 28.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 37.6 | 11.9 | 28.2 | 33.3 | 26.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 37.6 | 11.9 | 28.1 | 33.3 | 26.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.276 | 0.097 | 0.204 | 0.237 | 0.184 |
Dividends per Share |